Cellectar Biosciences Inc (CLRB)

[Crusader]

Who wants yesterday’s papers?

“Who wants yeste’s girl?”


Or even “who wants last week’s papers?.......


BRIEF-Fractionated Dosing Improves Tolerability And Safety Of Cellectar’S Clr 131 In R/R Multiple Myeloma Patients
REUTERS - 8:42 AM ET 8/20/2018
COMPANY NEWS

Aug 20 (Reuters) - Cellectar Biosciences Inc (CLRB)
:
* FRACTIONATED DOSING IMPROVES TOLERABILITY AND SAFETY OF CELLECTAR’S CLR 131 IN R/R MULTIPLE MYELOMA PATIENTS
* CELLECTAR BIOSCIENCES-DMC DETERMINED FRACTIONATED DOSE USED IN COHORT 5 TO BE SAFE & WELL TOLERATED & RECOMMENDED ADVANCEMENT TO A HIGHER DOSE COHORT
* CELLECTAR BIOSCIENCES INC (CLRB)
Loading...
- COMPANY INTENDS TO INITIATE A SIXTH COHORT AND TRANSITION ONGOING PHASE 2 TRIAL TO A FRACTIONATED DOSE Source text for Eikon: Further company coverage: ([e-mail])

So CLRB IS ALREADY IN AN “ONGOING” PHASE 2 TRIAL WITH CLR131 FOR MULTIPLE MYELOMA?

There could be some phase 2 news this year then, for this “pokey puppy”?